Study of Urinary Kallikrein to Enhance Collateral Circulation in Symptomatic Intracranial Atherosclerosis
Status:
Withdrawn
Trial end date:
2019-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether Urinary Kallikrein has an additional effect
on enhancing collateral circulation in symptomatic intracranial atherosclerotic patients
under clopidogrel and aspirin dual antiplatelet therapy.
Phase:
Phase 4
Details
Lead Sponsor:
Second Affiliated Hospital, School of Medicine, Zhejiang University